Assessment of target blood pressure in hypertensive patients.

Glossary definitions and references:

Scientific and Ayurvedic Glossary list for “Assessment of target blood pressure in hypertensive patients.”. This list explains important keywords that occur in this article and links it to the glossary for a better understanding of that concept in the context of Ayurveda and other topics.

1) Study (Studying):
The 'Study' refers to the comprehensive investigation conducted to assess the achievement of target blood pressure among hypertensive patients. It signifies rigorous data collection, analysis, and evaluation involving participants over a specified duration, crucial for deriving evidence-based conclusions that contribute to the field of hypertension management and patient care.

2) Blood:
In the context of the research, 'Blood' pertains to blood pressure measurements, a critical indicator of cardiovascular health. It is essential for diagnosing hypertension and evaluating the effectiveness of treatment regimens. The study focuses on systolic and diastolic blood pressure, which are vital for assessing patient health outcomes.

3) Table:
'Table' denotes the organized presentation of data that enables a clear comparison of parameters among the study participants. It facilitates better understanding of demographics, blood pressure measurements, and medication usage, aiding in the visualization of results, patterns, and trends that emerge from the research findings.

4) Drug:
'Drugs' encompasses various medications utilized in managing hypertension. This plural term indicates the diversity of pharmaceutical interventions available, reflecting on combined therapies. The study's focus on different classes of drugs illustrates the importance of tailored approaches to treatment, considering individual patient needs and responses to therapy.

5) Male:
'Male' signifies one demographic gender in the study sample. The research highlights the prevalence of hypertension among males compared to females, suggesting gender differences in risk factors, health behaviors, and treatment responses. This distinction is important for targeted healthcare strategies and understanding gender-based health disparities.

6) Disease:
'Diseases' refers to various medical conditions linked with hypertension, such as diabetes and cardiovascular disorders. The study discusses the association between hypertension and other diseases, elucidating the need for comprehensive care that addresses all co-existing ailments to reduce overall health risks and improve patient outcomes.

7) Beta:
'Beta' specifically refers to a class of medications used in hypertension management, namely beta-blockers. These drugs are significant due to their mechanism of action in lowering heart rate and improving heart function, which is pertinent to the study's analysis of prescription patterns and their effectiveness in controlling blood pressure.

8) Visit:
'Visit' relates to patient follow-ups during the study. Multiple visits allow for the monitoring of blood pressure changes over time, evaluating treatment efficacy, and making necessary adjustments to therapeutic regimens. The systematic approach of follow-up visits is essential for ongoing patient assessment and care improvement.

9) Food:
'Food' indicates dietary intake patterns among the study participants. Nutritional choices can influence blood pressure and overall health. The study addresses dietary habits as part of lifestyle factors that affect hypertension management, emphasizing the need for dietary education and interventions as part of comprehensive care plans.

10) Pharmacological:
'Pharmacological' pertains to the treatment strategies involving drugs to manage disease conditions like hypertension. This term highlights the importance of understanding medication actions, interactions, and effectiveness, which play a critical role in formulating and adjusting therapeutic plans for optimal patient outcomes in hypertension care.

11) Tiruchengode (Tiruchengodu):
Tiruchengode refers to the location where the study was conducted. The geographical context can influence health outcomes due to varying demographic and socio-economic factors. Recognizing local characteristics helps in understanding the applicability of the study’s findings within specific populations and enhancing local healthcare strategies.

12) Channel:
'Channel' may refer to calcium channel blockers, a drug class mentioned within the context of pharmacological management. These medications work by relaxing blood vessels and lowering blood pressure. Their inclusion in the study highlights the variety of treatment options available and their respective impacts on patient health management.

13) Reason:
'Reason' signifies the rationale behind conducting the study, which is to improve hypertension management and patient outcomes. By identifying factors influencing blood pressure control, the research aims to address underlying issues affecting treatment efficacy, awareness, and compliance, ultimately contributing to better healthcare practices.

14) Sabu:
'Sabu' references Raima Sabu, the corresponding author of the study. Her involvement signifies the contribution of pharmacy and healthcare professionals to research and clinical practice. Acknowledgment of authors is essential for attributing credit and recognizing their roles in advancing medical knowledge and patient care.

15) Pharmacotherapy:
'Pharmacotherapy' describes the treatment approach using medications for managing hypertension. The study emphasizes the role of selecting appropriate antihypertensive agents to achieve target blood pressure, indicating the essential nature of ongoing education and adaptation of pharmacotherapy to improve patient outcomes.

16) Measurement:
'Measurement' relates to the precise evaluation of blood pressure, patient demographics, and medication effectiveness throughout the study. Accurate measurement ensures that conclusions drawn about patient management and health outcomes are valid, reinforcing the importance of reliability in clinical research data collection.

17) Observation:
'Observation' refers to the systematic monitoring of study participants and their responses to treatment. This investigative aspect is crucial for gathering data that informs clinical decisions and enhances understanding of hypertension management practices among patients, as well as their adherence to prescribed therapies.

18) Discussion:
'Discussion' is where results from the study are interpreted and contextualized with existing literature. It allows for drawing meaningful conclusions from data, comparing findings with previous research, and proposing recommendations for future practice in hypertension management, stressing the importance of evidence-based approaches.

19) Education:
'Education' signifies the role of informing and counseling patients about hypertension and its management. The study highlights how effective patient education can improve adherence to treatment and aid in achieving target blood pressure, emphasizing the critical nature of understanding disease and management strategies in healthcare.

20) Observing:
'Observing' pertains to the actions involved in closely monitoring patients' blood pressure responses and treatment effectiveness throughout the study. This proactive approach is vital for adjusting treatment protocols and ensuring optimal patient care, illustrating the dynamic nature of managing hypertension in clinical practice.

21) Tamilnadu (Tamil-nadu):
'Tamilnadu' denotes the Indian state where the study was conducted. Regional socio-economic factors, healthcare access, and population characteristics unique to Tamilnadu can impact hypertension prevalence and management practices, reinforcing the significance of geographical context in understanding health disparities and tailoring healthcare services.

22) Medicine:
'Medicine' broadly encompasses the treatments and interventions utilized in patient care, particularly in managing hypertension. It highlights the integration of medical knowledge, therapeutic interventions, and ongoing evaluation to improve health outcomes, reflecting the multidimensional aspects of healthcare delivery and patient management.

23) Pregnant:
'Pregnant' refers to a specific population excluded from the study due to the risks associated with antihypertensive medication during pregnancy. This consideration emphasizes the importance of understanding how certain conditions require tailored management approaches and highlights the complexity of treating hypertension in vulnerable populations.

24) Allergy:
'Allergy' signifies a critical exclusion criterion in the study, where patients with known drug allergies were not included. This precaution ensures patient safety in pharmacotherapy, demonstrating the importance of comprehensive medical histories in selecting effective and safe treatment regimens for managing hypertension.

25) Family:
'Family' implies the support system surrounding the patient, influencing treatment adherence and lifestyle choices. The study recognizes the role of family dynamics in patient management and education, highlighting the need for involving patients' families in hypertension care strategies to improve health outcomes.

26) Kumar:
'Kumar' denotes Dr. S. P. Santhosh Kumar, the lead physician guiding the study. His expertise and oversight highlight the role of qualified healthcare professionals in conducting rigorous research, ensuring adherence to ethical standards and the reliability of findings that contribute to knowledge in hypertension management.

27) Field:
'Field' relates to the area of study, specifically cardiovascular health and hypertension management. This term underscores the importance of specialized knowledge and research in improving patient care and treatment effectiveness, emphasizing the need for continued development in the understanding of hypertension and its broader implications.

28) Pulse:
'Pulse' signifies a vital sign measured alongside blood pressure in the study, representing the patient's cardiovascular health. Monitoring pulse helps assess heart function and rhythm, providing additional insights that contribute to the comprehensive evaluation of treatment efficacy and patient well-being in managing hypertension.

29) Death:
'Death' highlights the severe consequences of untreated hypertension, as it is a significant risk factor for fatal cardiovascular events. The study's focus on managing blood pressure to prevent such outcomes emphasizes the critical nature of effective treatment strategies and patient education in avoiding premature mortality.

30) Litt:
'Litt' in this context likely relates to Dr. M. Karunanidhi, as 'Litt' indicates an honorary degree. Recognition of academic achievements underscores the integration of education and research in healthcare, emphasizing the importance of continuous professional development in improving practices related to hypertension management and patient care.